In this presentation, Garrett Murrin examines a clinical case involving a 68-year-old female patient who experienced a stroke, resulting in persistent headaches and a significant loss of her visual field. This case was kindly submitted by Dr. Larry Wallace.
The patient’s medical history includes early-stage glaucoma, hypertension, heart disease, and diabetes. Five months prior to the commencement of coMra therapy, she suffered a stroke that left her with a blind spot in her vision. Specifically, the patient experienced a loss of the left side of her visual field, which corresponded to the area of the brain where the stroke occurred on the right side.
The neurological impact affected the nerve pathways in both eyes. The treatment was focused on the specific area of the brain where the stroke occurred, as identified through clinical imaging.
The patient underwent a total of 12 treatments, administered once per week in an office setting. Each session lasted approximately five minutes, utilizing a frequency of 50 Hz. The application involved scanning both sides of the head, as well as five minutes of direct application at the site of the stroke, also at 50 Hz. This protocol was adapted from the Neurology 3 section of the coMra User Guide (pages 214 and 250).
The effectiveness of coMra therapy lies in the synergy of its components: ultrasound, magnetic fields, infrared laser, and colour LEDs. These modalities work in unison to support general cellular functions, specifically focusing on metabolism, ATP synthesis, and neurochemical messaging.
A stroke often results in a significant cellular energy deficit within the brain. Using the analogy of a fuel tank, Garrett Murrin explains that when the "tank" is full, the body is in a state of health; as energy levels drop, symptoms such as headaches become more pronounced.
Research, such as the 2010 study by Lapchak, demonstrates that transcranial laser treatment – a non-invasive procedure where the laser applicator is placed directly on the scalp – can effectively restore ATP levels. In the cited study, laser therapy not only restored ATP levels to normal but increased them by 77% beyond normal levels, providing the necessary energy for the body to initiate healing.
Furthermore, coMra therapy supports the regeneration process through neurochemical messaging. In an experiment by Andrews (2008), neural stem cells were shown to thrive when exposed to light, performing just as effectively as those treated with traditional growth factors. This confirms that coMra therapy not only boosts cellular energy stores but also actively supports the body’s regenerative mechanisms.
Following the 12-week course of treatment, a progress check revealed that the patient’s visual field had been completely restored to normal. Additionally, she reported that her headaches were significantly less frequent and less intense. Dr. Larry Wallace characterized these results as a substantial improvement, and the patient expressed great satisfaction with the outcome.
We extend our gratitude to Dr. Larry Wallace for sharing this successful case and to all who continue to explore the healing potential of coMra therapy.